Lateral Ankle Sprain and Platelet Rich Plasma
Ankle Injuries
About this trial
This is an interventional treatment trial for Ankle Injuries focused on measuring ankle sprain, platelet-rich plasma, ankle injuries
Eligibility Criteria
Inclusion Criteria:
- Acute lateral ankle sprain with no more of 48 hours of evolution
- First time lateral ankle sprain
- Grade 2 or 3
Exclusion Criteria:
- Associated pathologies like diabetes mellitus, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, neurologic or psychiatric issues
- Pregnant women
- Previous surgery of the foot and ankle
- Blood dyscrasias
Sites / Locations
- Universidad Autonoma de Nuevo Leon
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Short leg cast
Platelet-rich plasma
The patients in this group will be immobilize with a short leg cast for 14 days, and later they will be able to do physical rehabilitation and will be evaluated with American Orthopedic Foot and Ankle Society´s Ankle Hindfoot scale and Foot and Ankle Disability Index.
In this group, the patients will be receive a single dose of autologous platelet-rich plasma, and will be immobilized with a short leg cast. Posteriorly, they will be evaluated with American Orthopedic Foot and Ankle Society´s Ankle Hindfoot scale and Foot and Ankle Disability Index.